Lucira received CE Mark for both COVID-19 & flu and COVID-19 molecular tests
On May 9, 2022, Lucira Health announced that both its COVID-19 & Flu and COVID-19 molecular tests have…
WHO informed of a confirmed case of monkeypox in an individual who travelled from the United Kingdom to Nigeria
On May 7, 2022, WHO was informed of a confirmed case of monkeypox in an individual who travelled…
NIH launched clinical trial of Epstein-Barr virus vaccine
On May 6, 2022, the National Institute of Allergy and Infectious Diseases (NIAID) announced that it had launched…
WHO reported 14.9 million excess deaths associated with the COVID-19 pandemic in 2020 and 2021
On May 5, 2022, the World Health Organization (WHO) reported estimates that show the full death toll associated…
U.S. EPA and State of Florida approved second pilot project with Oxitec Friendlyï¾™ mosquitoes in the Florida Keys
On May 4, 2022, Oxitec announced approval from the Florida Department of Agriculture and Consumer Services, including reviews…
USDA issued a conditional license for mink Coronavirus
On Apr. 27, 2022, the U.S. Department of Agricultureï¾’s Animal and Plant Health Inspection Service announced it had…
Evolution of DNA
he Evolution of DNA is an Illustration with the very small, requiring magnification, to the very large. Cast…
Vekluryï¾® (Remdesivir) was first and only approved treatment for pediatric patients under 12 years of age with COVID-19
On Apr. 25, 2022, Gilead Sciences announced that the U.S. Food and Drug Administration (FDA) had approved a…
CureVac and GSKï¾’s bivalent second-generation mRNA accine candidate shown to be highly effective against SARS-CoV-2 variants
On Apr. 21, 2022, CureVac announced preclinical data demonstrating immune responses and protective efficacy of a bivalent second-generation…
Codiak announced new preclinical data supporting development of broadly protective pan beta-Coronavirus vaccine
On Apr. 20, 2022, Codiak BioSciences announced new preclinical data from its pan beta-coronavirus vaccine program, which aims…
Tonix Pharm announced results of retrospective observational database study in over 50,000 long COVID patients
On Apr. 20, 2022, Tonix Pharmaceuticals announced the results of a retrospective observational database study in over 50,000…
Pfizer and BioNTech data demonstrated high immune response following booster dose of COVID-19 vaccine in children 5 through 11 years of age
On Mar. 14, 2022, Pfizer and BioNTech announced positive results from a Phase 2/3 clinical trial evaluating the…
Regeneron antibody cocktail approved by European Commission to treat and prevent COVID-19
On Nov. 12, 2021, Regeneron announced that the U.S. Food and Drug Administration had extended by three months…
FDA authorized first COVID-19 diagnostic test using breath samples
On Apr. 14, 2022, the U.S. Food and Drug Administration issued an emergency use authorization (EUA) for the…
Merck announced FDA granted breakthrough therapy designation for V116, investigational 21-valent pneumococcal conjugate vaccine, for prevention of invasive pneumococcal disease and pneumococcal pneumonia in adults
On Apr. 14, 2022, Merck announced that V116, the companyï¾’s investigational 21-valent pneumococcal conjugate vaccine, had received Breakthrough…
FDA announced legislation clarifying the agency can regulate tobacco products containing nicotine from any source
On Apr. 13, 2022, the U.S. Food and Drug Administration announced that the legislation clarifying the agency can…
CureVac and GSK entered into Pandemic preparedness contract with German government Candidate, CV2CoV
On Apr. 11, 2022, CureVac and GSK announced that they had entered into a contract with the German…
Veruï¾’s novel COVID-19 drug candidate reduced deaths by 55% in hospitalized patients in interim analysis of phase 3 study
On Apr. 11, 2022, Veru announced positive efficacy and safety results from a planned interim analysis of the…
BioNTech granted pandemic preparedness contract by German Federal Ministry of Health
On Apr. 9, 2022, BioNTech announced it was granted a pandemic preparedness contract by the Federal Republic of…
NIH funded new tuberculosis research advancement centers
On Mar. 9, 2022, the National Institute of Allergy and Infectious Diseases (NIAID) announced four grant awards to…
Sorrento reported FDA clearance for phase 2/3 study for Abivertinib in treatment of pospitalized patients with severe pneumonia due to COVID-19
On Mar. 31, 2022, Sorrento Therapeutics announced that the FDA had given clearance to commence the Phase 3…
CureVac and GSK started clinical development of second-generation COVID-19 vaccine Candidate, CV2CoV
On Mar. 30, 2022, CureVac announced that the first participant was dosed in a Phase 1 study of…
US Food and Drug Administration revised EUA for sotrovimab due to Omicron BA.2 subvariant
On Mar. 25, 2022, GlaxoSmithKline and Vir Biotechnology announced that the US Food and Drug Administration had amended…
Icosavax announced topline interim results from its ongoing Phase 1/2 clinical trial of IVX-411, a VLP vaccine candidate displaying the SARS-CoV-2 receptor-binding domain (RBD).
On Mar. 25, 2022, Icosavax announced the first subjects had been dosed with IVX-411, a virus-like particle (VLP)…
WHO established the Global Centre for Traditional Medicine in India
On Mar. 25, 2022, the WHO and the Government of India signed an agreement to establish the WHO…
Quest Diagnostics granted CDC contract to support COVID-19 infection and vaccination seroprevalence research
On Mar. 23, 2022, Quest Diagnostics announced that it had been granted a contract by the Centers for…
Windtree announced results from phase 2 study of lucinactant for COVID-19 associated ARDS and Lung Injury
On Mar. 22, 2022, Windtree Therapeutics announced results from its Phase 2 study of lucinactant (KL4 surfactant) for…
NIH launched program to offer molecular characterization of childhood cancers
On Mar. 21, 2022, in support of the Cancer Moonshot? goal of fostering data sharing in cancer research,…
Eiger’s single-dose Peginterferon Lambda for COVID-19 reduced risk of hospitalization or ER visits by 50% in vaccinated population
On Mar. 17, 2022, Eiger BioPharmaceuticals announced that Peginterferon Lambda (Lambda) significantly reduced the risk of COVID-19-related hospitalizations…
Roche provided molecular testing solutions to identify and differentiate SARS-CoV-2 Omicron variants of concern
On Mar. 16, 2022, Roche announced available testing solutions that can identify the SARS-CoV-2 B.1.1.529 variant and differentiate…